BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin XG, Zeng JH, Lin P, Mo WJ, Li Q, Feng ZB, Luo DZ, Yang H, Chen G, Zeng JJ. Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data. Pathol Res Pract 2019;215:414-26. [PMID: 30455130 DOI: 10.1016/j.prp.2018.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen ZX, Huang HQ, Wen JY, Qin LS, Song YD, Fang YY, Zeng DT, Huang WJ, Qin XG, Gan TQ, Luo J, Li JJ. Active Enhancer Assessment by H3K27ac ChIP-seq Reveals Claudin-1 as a Biomarker for Radiation Resistance in Colorectal Cancer. Dose Response 2021;19:15593258211058981. [PMID: 34987334 DOI: 10.1177/15593258211058981] [Reference Citation Analysis]
2 Baptista B, Riscado M, Queiroz J, Pichon C, Sousa F. Non-coding RNAs: Emerging from the discovery to therapeutic applications. Biochemical Pharmacology 2021;189:114469. [DOI: 10.1016/j.bcp.2021.114469] [Reference Citation Analysis]
3 Baptista B, Riscado M, Queiroz JA, Pichon C, Sousa F. Non-coding RNAs: Emerging from the discovery to therapeutic applications. Biochem Pharmacol 2021;189:114469. [PMID: 33577888 DOI: 10.1016/j.bcp.2021.114469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
4 Tabatabaeian H, Peiling Yang S, Tay Y. Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis. Cancers (Basel) 2020;12:E3264. [PMID: 33158279 DOI: 10.3390/cancers12113264] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
5 Lin Z, Lu S, Xie X, Yi X, Huang H. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomed Pharmacother 2020;131:110768. [PMID: 33152930 DOI: 10.1016/j.biopha.2020.110768] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
6 Zimta AA, Sigurjonsson OE, Gulei D, Tomuleasa C. The Malignant Role of Exosomes as Nanocarriers of Rare RNA Species. Int J Mol Sci 2020;21:E5866. [PMID: 32824183 DOI: 10.3390/ijms21165866] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19:62. [PMID: 32192494 DOI: 10.1186/s12943-020-01185-7] [Cited by in Crossref: 140] [Cited by in F6Publishing: 159] [Article Influence: 70.0] [Reference Citation Analysis]
8 Rong MH, Zhu ZH, Guan Y, Li MW, Zheng JS, Huang YQ, Wei DM, Li YM, Wu XJ, Bu HP, Peng HL, Wei XL, Li GS, Li MX, Chen MH, Huang SN. Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma. PeerJ 2020;8:e8380. [PMID: 32095320 DOI: 10.7717/peerj.8380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Wei L, Wang X, Lv L, Liu J, Xing H, Song Y, Xie M, Lei T, Zhang N, Yang M. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer. 2019;18:147. [PMID: 31651347 DOI: 10.1186/s12943-019-1086-z] [Cited by in Crossref: 159] [Cited by in F6Publishing: 174] [Article Influence: 53.0] [Reference Citation Analysis]